Delivery Order SPE2DB22D2007-SPE2DB22FH9LE
Award Date
8/3/22
Potential Completion Date
8/4/22
Potential Value
$8.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4,563,556,647 Diclofenac Potassium 50 mg tablets in 100-count bottles, with a potential value of $4,930.76 and a completion date of February 6, 2024. No set-aside designation was used for this award. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,395.27, is for the delivery of 100 mg tablets of the drug diclofenac sodium extended-release. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2023. The contract is not designated with a set-aside....
This federal contract award, valued at $1,493.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4,568,201,898 units of Diclofenac Sodium Delayed-Release 75 mg tablets. The contract has a firm fixed price and an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,462.54, is for the delivery of 100 mg diclofenac sodium extended-release tablets. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded to Amerisourcebergen Drug Corp (Amerisourcebergen), a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,314.37 firm fixed price contract is for the delivery of 1,000 units of Diclofenac Sodium Delayed-Release 75 mg Tablets. Amerisourcebergen, the prime contractor, serves as a key supplier of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
This federal contract award is for the delivery of DICLOFENAC SOD ER 100 MG TAB 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 30, 2024 with a ceiling value of $1,454.21. The contract is a Firm Fixed Price Delivery Order with a completion date of December 31, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,944.14 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $88,678.24 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical and medical supply distributor. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, which serves as Amerisourcebergen's primary vehicle for providing a wide range of medications, medical devices, and supplies to support the Department of...
This federal contract award, SPE2DB20D1004|SPE2DB25FNGQJ, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568037981 - DICLOFENAC-MISOPROST 50-0.2 MG 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,109.05 and an ultimate completion date of April 28, 2025. The contract is not set aside and was open...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,242.58 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the...